期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胶质瘤患者抑癌基因RASSF1A启动子区甲基化研究

Research on promoter hypermethylation of RASSF1A tumor suppressor gene in glioma
下载PDF
导出
摘要 目的探讨RASSF1A抑癌基因在胶质瘤组织及脑正常组织中甲基化程度及与临床特征的关系。方法46例脑胶质瘤组织及6例脑正常组织采自手术患者。用甲基化特异性聚合酶链反应(MS-PCR)方法检测46例胶质瘤(其中包括星形细胞瘤19例,室管膜瘤16例,胶质母细胞瘤11例)及6例脑正常组织中RASSF1A基因甲基化状态。并对RASSF1甲基化发生率与临床各因素之间的关系进行分析。结果①46例脑胶质瘤组织DNA标本中RASSF1A基因甲基化发生率为65.2%(30/46);6例脑正常组织中RASSF1A基因启动子未发生甲基化;RASSF1A在胶质瘤和脑正常组织之间发生甲基化率比较差异有显著性,(P=0.017,P<0.05)。在46例脑胶质瘤中RASSF1A有30例发生甲基化,其中低级别组14例(14/26),高级别组16例(16/20),两组之间甲基化率比较无明显差异,(P>0.05)。其中星形细胞瘤,室管膜瘤,胶质母细胞瘤甲基化发生频率分别为63.2%(12/19),68.8%(11/16),63.6%(7/11)。在各组之间甲基化发生率比较均无统计学意义,(P>0.05)。②RASSF1A基因甲基化程度与脑胶质瘤病理分型、肿瘤大小之间无显著相关性。结论RASSF1A在胶质瘤中有甲基化发生,在脑正常组织中未发生甲基化,检测胶质瘤中RASSF1A基因启动子区甲基化情况对临床判断肿瘤发生发展有指导意义。 Objective To investigate the promoter hypermethylation status of suppressor gene RASSF1A in glioma and normal brain tissues and its clinical pathological significance. Methods The promoter methylation status of the promoter region of RASSF1A was analyzed by methylation specific-polymerase chain reaction （ MSPCR） in 46 case of surgical resected gliomas （including 19 cases of astrocytoma, 16 cases of apendymoma, 11 case of glioblastomas） and 6 cases of normal brain tissues. Results The promoter methylation rate of RASSF1A was 65.2% （30/46）in glioma and 0 （0/6） in normal brain tissues. The frequency of promoter hypermethylation rate of RASSF1A in glioma and normal brain tissues presented significant correlation （65.2% vs 0, P = 0.017, P 〈 0.05 ）. The frequency of promoter methylation rate of RASSF1A in astrocytoma, ependymoma and glioblastomas were 63.2% （12/19）, 68.8% （11/16）, and 63.6% （7/11）, respectively, with no significant difference among them （P 〉0.05 for all）. However, the promoter methylation of RASSF1A in gliomas was not statistically related to the clinical characteristics of patients （differentiation grade and the size of tumors）. Conclusion There is a significant frequency of promoter methylation of RASSF1A in glioma, but not in normal brain tissues. The promoter methylation of RASSF1A in glioma may be an important molecular change and may contribute to the cause and development of glioma.
作者 董欣明 刘云会 潘尉然
机构地区 中国医科大学附属盛京医院神经外科
出处 《中华神经外科疾病研究杂志》 CAS 2008年第3期232-235,共4页 Chinese Journal of Neurosurgical Disease Research
关键词 胶质瘤 RASSF1A 甲基化 甲基化特异性聚合酶链反应 Glioma RASSF1 Methylation MS-PCR
分类号 R739.41 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 [J]. Nat Genet, 2000, 25(3):315-319.
  • 2Dammann R, Strunnikova M, Schagdarsurengin U, et al. CpG island methylation and expression of tumour-associated genes in lung carcinoma [J]. Eur J Cancer, 2005, 41 (8) : 1223 - 1236.
  • 3Yeo W, Wong WL, Wong N, et al. High frequency of promoter hypermethylation ASSF1A in tumorous and non-tumourous tissue of breast cancer [J]. Pathology, 2005, 37(2) : 125 -130.
  • 4Pfeifer GP, Yoon JH, Liu L, et al. Methylation of the RASSF1A genes in human cancers [J]. Biol Chem, 2002, 383(6) : 907 -914.
  • 5Michalowski MB, de Fraipont F, Michelland S, et al. Methylation of the RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma [J]. Cancer Genet Cytogenet, 2006, 166(1 ): 74-81.
  • 6王喆,曹培成,张振兴,王成东,闫红梅,王道奎,王永和,管立学.p16基因CpG岛甲基化与胶质瘤生物学特性的关系[J].中华神经外科疾病研究杂志,2007,6(4):311-314. 被引量：5
  • 7Horiguchi K, Tomizawa Y, Tosaka M, et al. Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors [J]. Oncogene, 2003, 22(49): 7862-7865.
  • 8Gao Y, Guan M, Su B, et al. Hypermethylation of the RASSF1A gene in gliomas [J]. Clin Chim Acta, 2004, 349(1 -2) : 173 -179.
  • 9Dammann R, Takahashi T, Pfeifer GP. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinoma [J]. Oncogene, 2001, 20(27): 3563- 3567.
  • 10Yan PS, Shi H, Rahmatpanah F, et al. Differential distribution of DNA methylation with in the RASSF1A CpG island in breat cancer [J]. CancerRes, 2003, 63(21):6178-6186.

二级参考文献12

  • 1高方友,刘健,杨华,刘沣.p16在星形胶质细胞瘤患者生存分析中的意义[J].中华神经外科疾病研究杂志,2006,5(4):307-310. 被引量：2
  • 2Dong SM,Pang JC,Poon WS,et al.Concurrent hypermethylation of multiple genes in associated with grade of oligodendrogial tumors[J].J Neuropatho Exp Neurol,2001,60(8):808-816.
  • 3Park SH,Jung KC,Ro JY,et al.5'CpG island methylation of p16 in associated with absence of p16 expression in glioblastomas[J].J Korean Med Sci,2000,15(5):555-559.
  • 4Wolter M,Reifenberger J,Blaschke B,et al.Oligodendroglial tumor frequently demonstrate hypermeyhlation of the CDKN2A (MST1,P16INK4a),p14 ARF and CDKNB (MST2,P15INK4b) tumor suppression genes[J].J Neuropathol Exp Neurol,2001,60(12):1170-1180.
  • 5Watanabe T,Nakamura M,Yonekawa Y,et al.Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogilomas[J].Act Neuropathol (Berl),2001,101(3):185-189.
  • 6De Souza Nascimento P,Maciel CM,Kawamura MT,et al.Moleoular analysis of CDKN2 (p16) in gliomas associated with clinical data[J].Oncol Rep,2001,8(5):1039-1043.
  • 7Alonso ME,Bello MJ,Gonzalez-Gomez P,et al.Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas[J].Cancer Genet Cytogenet,2003,144(2):134-142.
  • 8Herman JG,Graff JR,Myohanen S,et al.Methylation-soeciffic PCR:a novel PCR assay for methylation status of CpG islands[J].Proc Natl Acad Sci USA,1996,93(18):9821-9826.
  • 9Fueyo J,Gomez-Manzano C,Bruner JM,et al.Hypermethylation of the CpG island of p16/CDKN corrletates with gene inactivation in glimas[J].Oncogene,1996,13(8):1615-1619.
  • 10Ono Y,Tamiya T,Ichikawa T,et al.Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices[J].J Neuropathol Exp Neurol,1996,55(10):1026-1031.

共引文献15

中华神经外科疾病研究杂志
2008年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部